New Markets

Besides the dental market, Fulandis International AG recently further diversified into biotec applications in 2016, mainly driven by new achievements in genomics, such as CRISPR-CAS9 based gene editing methods.

In 2017 the product range was expanded further within biotec and IVD market segments.

Today the company is selling a wide range of high quality products from Japan and Europe into Asian markets, but also helps high quality Asian suppliers to enter EU markets.